ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,086.49
      0.61%
      US Tech 100
      20,896.00
      1.07%
      Dow Jones
      45,014.04
      0.69%
      Brent Oil
      72.29
      -0.19%
      Bitcoin
      102,981.18
      4.28%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Biora Therapeutics Inc (BIOR) Quote

      Biora Therapeutics Inc

      Biora Therapeutics Inc (BIOR)

      NASDAQ
      1.43
      -0.225
      (-13.60%)
      Closed December 04 4:00PM
      Delayed by 15 minutes
      1.44
      0.01
      (0.70%)
      After Hours: 7:54PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.44
      Bid
      1.47
      Ask
      1.50
      Volume
      285,717
      1.3122 Day's Range 1.66
      1.40 52 Week Range 19.90
      Market Cap
      5.296M
      Previous Close
      1.655
      Open
      1.65
      Last Trade
      1
      @
      1.4499
      Last Trade Time
      Financial Volume
      $ 421,618
      VWAP
      1.4756
      Average Volume (3m)
      181,632
      Shares Outstanding
      3,677,747
      Dividend Yield
      -
      PE Ratio
      -0.04
      Earnings Per Share (EPS)
      -33.75
      Revenue
      4k
      Net Profit
      -124.12M

      About Biora Therapeutics Inc

      Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bicara.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $1.66. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 1.40 to $ 19.90.

      Biora Therapeutics currently has 3,677,747 shares outstanding. The market capitalization of Biora Therapeutics is $6.09 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.04.

      Ask ADVFN Intelligence (AI)

      BIOR Latest News

      More News

      Form 8-K - Current report

      November 15 2024
      Edgar (US Regulatory)

      Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

      Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain...

      November 14 2024
      GlobeNewswire Inc.

      Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

      SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and...

      November 07 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 29 2024
      Edgar (US Regulatory)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.37-20.44198895031.812.10581.41111901.87341524CS
      4-1.45-50.17301038062.893.11.41287282.10387402CS
      12-4.973-77.54561047876.4136.81.41816324.52565967CS
      26-5.018-77.70207494586.4587.91.41939915.76674249CS
      52-11.06-88.4812.519.91.43064198.80988747CS
      156-213.56-99.3302325581215287.51.484881697.50240349CS
      260-213.56-99.3302325581215287.51.484881697.50240349CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CYCNCyclerion Therapeutics Inc
      $ 6.10
      (278.88%)
      		141.56M
      BLUEbluebird bio Inc
      $ 0.7396
      (106.30%)
      		79.23M
      SMXSMX Security Matters Public Company
      $ 0.381378
      (95.78%)
      		826.63M
      SRMSRM Entertainment Inc
      $ 1.15
      (82.51%)
      		143.64M
      CNEYCN Energy Group Inc
      $ 0.5349
      (69.49%)
      		164.13M
      RLMDRelmada Therapeutics Inc
      $ 0.6408
      (-76.87%)
      		17.41M
      MIGIMawson Infrastructure Group Inc
      $ 0.6885
      (-63.95%)
      		23.3M
      MONDMondee Holdings Inc
      $ 0.192
      (-34.94%)
      		4.05M
      ORISOriental Rise Holdings Ltd
      $ 8.02
      (-32.89%)
      		664.21k
      HTLMHomesToLife Ltd
      $ 3.10
      (-27.57%)
      		162.81k
      SMXSMX Security Matters Public Company
      $ 0.381378
      (95.78%)
      		826.62M
      SVMHSRIVARU Holding Ltd
      $ 0.023499
      (6.81%)
      		469.52M
      HTOOFusion Fuel Green PLC
      $ 0.5199
      (63.49%)
      		279.1M
      NVDANVIDIA Corporation
      $ 145.14
      (3.48%)
      		225.27M
      CNEYCN Energy Group Inc
      $ 0.5349
      (69.49%)
      		157.88M

      BIOR Discussion

      View Posts
      Monksdream Monksdream 1 month ago
      BIOR, new 52 week low
      👍️0
      Monksdream Monksdream 1 month ago
      BIOR, new 52 week low
      👍️0
      The Night Stalker The Night Stalker 6 months ago
      nice
      👍️0
      Arnold25764 Arnold25764 7 months ago
      Any possible catalyst here?
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR 10Q due 3/26
      👍️0
      Monksdream Monksdream 9 months ago
      BIOR under $2
      👍️0
      glenn1919 glenn1919 9 months ago
      BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 9 months ago
      BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 12 months ago
      BIOR new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      BOIR new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      BIOR new 52 week low
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      https://finviz.com/quote.ashx?t=BIOR&p=d

      https://dilutiontracker.com/app/search/BIOR
      👍️0
      Awl416 Awl416 1 year ago
      Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
      👍️0
      retireat40 retireat40 1 year ago
      Looked good this morning at 2.66 but a crappy close.
      👍️0
      Monksdream Monksdream 1 year ago
      BIOR Barchart Bottom 100
      Biora Therapeutics Inc NASDAQ: BIOR



      GoSymbol lookup
      Health Care : Biotechnology | Small Cap ValueCompany profile
      Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
      👍️0

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      Delayed Upgrade Clock